about
Preventing a Mass Disease: The Case of Gallstones Disease: Role and Competence for Family PhysiciansHelicobacter pylori infection is associated with gallstones: Epidemiological survey in China.Prevalence and associated metabolic factors of gallstone disease in the elderly agricultural and fishing population of taiwan.Metabolic syndrome and gallstone diseaseGender and metabolic differences of gallstone diseasesEffect of statin use on outcome of symptomatic cholelithiasis: a case-control study.Association of caveolin-3 and cholecystokinin A receptor with cholesterol gallstone disease in miceBiliary physiology and disease: reflections of a physician-scientist.ApoB-100, ApoE and CYP7A1 gene polymorphisms in Mexican patients with cholesterol gallstone disease.Comparative proteomic analysis of gallbladder bile proteins related to cholesterol gallstonesRoles of ApoB-100 gene polymorphisms and the risks of gallstones and gallbladder cancer: a meta-analysis.Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale studySignificantly increased risk of cardiovascular disease among patients with gallstone disease: a population-based cohort studyAbundant pleiotropy in human complex diseases and traits.Chemical composition of gallstones from Al-jouf province of saudi arabia.Dietary patterns and risk of gallbladder disease: a hospital-based case-control study in adult women.The APOB gene polymorphism in the pathogenesis of gallstone disease in pre- and postmenopausal women.Relation of cholesterol metabolism to pediatric gallstone disease: a retrospective controlled study.Concept of the pathogenesis and treatment of cholelithiasis.Effect of ezetimibe on the prevalence of cholelithiasis.Lipids, obesity and gallbladder disease in women: insights from genetic studies using the cardiovascular gene-centric 50K SNP array.Prevalence of ABCB4 polymorphisms in gallstone disease in han-Chinese population.Ursodeoxycholic acid lowers bile lithogenicity by regulating SCP2 expression in rabbit cholesterol gallstone models.The prevalence and risk factors for gallstone disease.Statins as potential treatment for cholesterol gallstones: an attempt to understand the underlying mechanism of actions.Hepatobiliary anomalies associated with ABCB4/MDR3 deficiency in adults: a pictorial essay.Nonalcoholic fatty liver disease and cholesterol gallstones: which comes first?The association between renal stone disease and cholesterol gallstones: the easy to believe and not hard to retrieve theory of the metabolic syndrome.Physical Activity and the Biliary Tract in Health and Disease.Body mass index, alcohol, tobacco and symptomatic gallstone disease: a Swedish twin study.Helicobacter pylori infection is positively associated with gallstones: a large-scale cross-sectional study in Japan.Polymorphism and Expression Profile of Cholecystokinin Type A Receptor in Relation to Gallstone Disease Susceptibility.Retinol-binding protein 4 as a risk factor for cholesterol gallstone formation.ATP binding cassette and cholecystokinin A receptor genetic variations in gallstone susceptibility.Rare SCARB1 mutations associate with high-density lipoprotein cholesterol but not with coronary artery disease.Effects of different intraabdominal pressure levels on oxidative stress markers in laparoscopic cholecystectomy
P2860
Q26741095-00918D7F-0734-4CAD-BCA7-627ECC2AD14CQ30405017-1441BE12-5D10-4E34-AEDC-029255FA9668Q30440482-740BD629-9C92-4A54-924E-B8362E13E5FBQ30464508-0901310C-4AD9-4658-B6D7-0E8FFCFD6B22Q30490117-AF57A5A1-5FD3-4274-9316-4816173B4195Q33861377-4B52C839-ECCA-40D1-97E2-5A2323C9B40CQ33948398-4C908F6F-FB2F-48E9-AEB1-1E13D886C176Q34108895-AF6ECB46-5E83-4E2C-8BA0-9087881043B2Q34183183-B4872693-3DD7-4170-A9AA-EB5C2043E471Q34563185-471360AA-8848-4561-B36A-F82D70858DDCQ34700327-3B8BBD63-E884-47F1-91C4-E02907CE1245Q35003443-09E7DB76-F442-470D-88D6-497FCA475080Q35009445-AE5C717C-9917-494B-9653-7CCA49C3925EQ35542127-D40C0EC6-50AA-405D-8CB6-1B4628D4CEFDQ35550433-CBCAAC5C-8FF6-4A0D-89A9-F1108A0451F9Q35627333-999F9DB9-A932-4A64-BFC6-2665F0AB3B65Q35632508-D7A59C1B-4A62-4642-8542-20EB6DA2608BQ35677816-4142C6B0-7916-4329-BF39-FF659C8E4D21Q35809361-4BB04E83-9A9D-4BB8-930E-FE7A97F2976EQ36357484-E24D7EA2-16ED-41DE-9EC1-ABEE878737B5Q36376710-1F29C619-AC66-4AA4-B03B-5F595B46055AQ36841388-4C2CB698-16FC-42BA-9711-841A2F4EF234Q37400102-5F556162-858D-4BA0-9B58-5A97E12895BCQ37509086-89549967-3A9E-42B7-B84E-93ECF6BDBA93Q37951499-6F48CE74-362C-4B74-BC21-CE34423CFBACQ38099577-4BAB6BBE-28D8-4172-9FF6-641D1843935DQ38197380-60DA19D6-80B2-4AC8-ABD4-013DF5606290Q38200139-39ED5F47-B186-4D8E-949C-8F204001B844Q38526062-AE5E6DC3-CB41-4B17-80E6-C69E3077A092Q46972741-1FBBC205-F36F-416D-980A-30C6897EE748Q50189827-91A6C11C-6D13-4334-BC20-A36EEA288929Q50505711-1637AD32-E5BA-4521-A093-B771C7C27956Q51344561-CBD6EAFB-8273-4D4C-B1CB-0230729EAEDEQ54944078-1D321028-BBF6-4E6B-8218-AF4FD0643393Q55446406-9DFE34E1-2D88-448A-B818-C19563644A76Q58772731-061760B6-C722-4B01-8872-43468AA86560
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Gallstone disease.
@ast
Gallstone disease.
@en
Gallstone disease.
@nl
type
label
Gallstone disease.
@ast
Gallstone disease.
@en
Gallstone disease.
@nl
prefLabel
Gallstone disease.
@ast
Gallstone disease.
@en
Gallstone disease.
@nl
P2860
P1476
Gallstone disease.
@en
P2093
Einarsson C
Marschall HU
P2860
P304
P356
10.1111/J.1365-2796.2007.01783.X
P407
P577
2007-06-01T00:00:00Z